US Stock MarketDetailed Quotes

RVMD Revolution Medicines

Watchlist
  • 55.090
  • +1.590+2.97%
Close Nov 1 16:00 ET
  • 55.000
  • -0.090-0.16%
Post 20:02 ET
9.20BMarket Cap-14809P/E (TTM)

Revolution Medicines Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Revolution Medicines Q3 2024 Estimates Date

Currency：USDNov 6, 2024

Estimate YoY
Revenue
807.69K
--
EPS
-0.89
+9.74%
Analyst Rating
Strong Buy

Oct 31, 2024

Revolution Medicines Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 13 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 807.690K--
Nov 6, 20242024/Q3-- / 807.690K--
Aug 7, 20242024/Q20.000 / 807.690K--
May 8, 20242024/Q10.000 / 674.200K--
Feb 26, 20242023/Q4742.000K / 1.200M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 807.690K--
Nov 6, 20242024/Q3-- / 807.690K--
Aug 7, 20242024/Q20.000 / 807.690K--
May 8, 20242024/Q10.000 / 674.200K--
Feb 26, 20242023/Q4742.000K / 1.200M--

Unlock Free Earnings Estimates

Revolution Medicines Earnings Reports

  • 10-Q: Q2 2024 Earnings Report

    Aug 7 16:18 ET

  • 10-Q: Q1 2024 Earnings Report

    May 8 16:19 ET

  • Revolution Medicines | 10-K: FY2023 Annual Report

    Feb 26 22:23 ET

  • Revolution Medicines | 10-Q: Q3 2023 Earnings Report

    Nov 6, 2023 16:09 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Oct 31, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data